Le Lézard
Classified in: Health
Subjects: PDT, BFA

Sterling Ridge Orthopaedic & Sports Medicine Sets Milestone with Dr. Paul Chin's Innovative Shoulder Replacement Surgery


THE WOODLANDS, Texas, May 2, 2024 /PRNewswire/ -- Sterling Ridge Orthopaedics & Sports Medicine proudly announces a groundbreaking achievement in orthopaedic surgery with Dr. Paul Chin, MD, PhD, FAAOS, FAANA, at the forefront. Dr. Chin made history by becoming the first orthopaedic surgeon in Texas to use Medacta's NextAR Shoulder Augmented Reality Surgical Platform.

Shoulder replacement surgery is a complex procedure to relieve pain and restore function to shoulders damaged by arthritis, severe fractures, or other debilitating conditions. Dr. Chin's approach incorporates cutting-edge NextAR technology, offering personalized 3D planning for precise surgical outcomes. This innovative method enhances surgical accuracy with the goal to significantly advance patient outcomes.

Dr. Chin practices at Sterling Ridge Orthopaedics & Sports Medicine located in The Woodlands, Texas, and this orthopaedic advance reaffirms the clinic's commitment to providing state-of-the-art healthcare services to the community. Dr. Chin's expertise and advanced technological tools exemplify the clinic's dedication to excellence in orthopaedic care.

"We are immensely proud of Dr. Paul Chin's groundbreaking achievement," said Stacy Lund, Director of Operations at Sterling Ridge Orthopaedics & Sports Medicine. "His innovative approach to shoulder replacement surgery demonstrates our clinic's commitment to delivering the highest quality of care through cutting-edge technology."

Dr. Chin's accomplishment underscores Sterling Ridge Orthopaedics & Sports Medicine's position as a leader in orthopaedic innovation. By harnessing the power of NextAR technology, the clinic continues to redefine standards in orthopaedic surgery, ultimately improving patient outcomes and quality of life.

For more information about Sterling Ridge Orthopaedics & Sports Medicine and Dr. Paul Chin, please visit www.srosm.com or www.paulchinmd.com

About Sterling Ridge Orthopaedics & Sports Medicine:
Sterling Ridge Orthopaedics & Sports Medicine is a premier orthopaedic clinic in The Woodlands, Texas. Committed to providing exceptional care, the clinic offers various orthopaedic services, including sports medicine, joint replacement, and orthopaedic surgery. With a team of experienced physicians and state-of-the-art facilities, Sterling Ridge Orthopaedics & Sports Medicine delivers comprehensive and personalized treatment to patients of all ages.

About Dr. Paul Chin, MD, PhD, FAAOS, FAANA:
Dr. Paul Chin is a distinguished orthopaedic surgeon specializing in shoulder and elbow surgery. With extensive training and expertise, Dr. Chin is at the forefront of orthopaedic innovation, continuously striving to advance surgical techniques and improve patient outcomes. As a leader in the field, Dr. Chin is dedicated to providing compassionate and comprehensive care to his patients, ensuring the highest quality of orthopaedic treatment.

Contact:
Stacy Lund
281-364-1112
[email protected]

SOURCE Sterling Ridge Orthopeadics & Sports Medicine


These press releases may also interest you

at 07:30
Foundation Fighting Blindness to Host VISIONS 2024 Conference
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...

at 07:30
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...

at 07:30
Marijuana Reclassification Must Account for Highway Safety Risks Says Trucking Industry
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...

at 07:30
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
-    AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)-    Data to be presented from...

at 07:28
/DISREGARD RELEASE: OsteoStrong/
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire. SOURCE...

at 07:05
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...

More news about Health...


News published on and distributed by: